Portal de Periódicos da CAPES

Neurochemistry and Neurotoxicity of 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

1990; Wiley; Volume: 54; Issue: 1 Linguagem: Inglês

10.1111/j.1471-4159.1990.tb13277.x

1471-4159

Dennis J. McKenna, Stephen J. Peroutka,

Neuroscience and Neuropharmacology Research

Journal of NeurochemistryVolume 54, Issue 1 p. 14-22 Neurochemistry and Neurotoxicity of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") Dennis J. McKenna, Dennis J. McKenna Department of Neurology, Stanford University School of Medicine, Stanford, California, U.S.A.Search for more papers by this authorStephen J. Peroutka, Corresponding Author Stephen J. Peroutka Department of Neurology, Stanford University School of Medicine, Stanford, California, U.S.A.Address correspondence and reprint requests to Dr. S. J. Peroutka at Department of Neurology, Stanford University School of Medicine, Stanford, CA 94305, U.S.A.Search for more papers by this author Dennis J. McKenna, Dennis J. McKenna Department of Neurology, Stanford University School of Medicine, Stanford, California, U.S.A.Search for more papers by this authorStephen J. Peroutka, Corresponding Author Stephen J. Peroutka Department of Neurology, Stanford University School of Medicine, Stanford, California, U.S.A.Address correspondence and reprint requests to Dr. S. J. Peroutka at Department of Neurology, Stanford University School of Medicine, Stanford, CA 94305, U.S.A.Search for more papers by this author First published: January 1990 https://doi.org/10.1111/j.1471-4159.1990.tb13277.xCitations: 124Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES Bakhit C., Morgan M. E., and Gibb J. W. (1981) Long-term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptamine in various regions of the rat brain. Neuropharmacology 20, 1135–1140. 10.1016/0028-3908(81)90053-8 CASPubMedWeb of Science®Google Scholar Battaglia G., Yeh S. Y., O'Hearn E., Molliver M. E., Kuhar M. J., and De Souza E. B. (1987) 3,4-Methylenedioxymethamphet-amine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. J. Pharmacol. Exp. Ther. 141, 911–916. Google Scholar Battaglia G., Brooks B. P., Kulsakdinun C., and De Souza E. B. (1988a) Pharmacologic profile of MDMA (3,4-methylenedioxy-methamphetamine) at various brain recognition sites. Eur. J Pharmacol. 149, 159–163. 10.1016/0014-2999(88)90056-8 CASPubMedWeb of Science®Google Scholar Battaglia G., Yeh S. Y., and De Souza E. B. (1988b) MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol. Biochem. Behav. 29, 269–274. 10.1016/0091-3057(88)90155-4 CASPubMedWeb of Science®Google Scholar Battaglia G., Zaczek R., and De Souza E. B. (1989) MDMA effects in brain: pharmacologic profile and evidence of neurotoxicity from neurochemical and autoradiographic studies, in MDMA: "Ecstasy" and/or Human Neurotoxin ( S. J. Peroutka, ed), pp. 171–199. Kluwer Academic Publishers, Norwell , Massachusetts . Google Scholar Clineschmidt B. V., Zacchei A. G., Totaro J. A., Pfleuger A. B., McGuffin J.C., and Wishousky T. I. (1978) Fenfluramine and brain serotonin. Ann. NY Acad. Sci. 305, 222–241. 10.1111/j.1749-6632.1978.tb31526.x CASPubMedGoogle Scholar Commins D. L., Vosmer G., Virus R. M., Woolverton W. L., Schuster C. R., and Seiden L. S. (1987) Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. J. Pharmacol. Exp. Ther. 241, 338–345. CASPubMedWeb of Science®Google Scholar De Souza E. B. and Kuyatt B. L. (1987) Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain. Synapse 1, 488–496. 10.1002/syn.890010513 PubMedWeb of Science®Google Scholar Downing J. (1986) The psychological and physiological effects of MDMA on normal volunteers. J. Psychoactive Drugs 18, 335–340. 10.1080/02791072.1986.10472366 PubMedWeb of Science®Google Scholar Finnegan K. T., Ricaurte G. A., Ritchie L. D., Irwin I., Peroutka S. J., and Langston. W. (1988) Orally administered MDMA causes a long-term depletion of serotonin in rat brain. Brain Res. 447, 141–144. 10.1016/0006-8993(88)90974-2 CASPubMedWeb of Science®Google Scholar Fuller R. W. and Hemrick-Luecke S. K. (1982) Further studies on the long-term depletion of striatal dopamine in iprindole-treated rats by amphetamine. Neuropharmacology 21, 433–438. 10.1016/0028-3908(82)90027-2 CASPubMedWeb of Science®Google Scholar Fuller R. W., Perry K. W., and Molloy B. B. (1975) Reversible and irreversible phases of serotonin depletion by 4-chloroamphet-amine. Eur. J. Pharmacol. 33, 119–124. 10.1016/0014-2999(75)90145-4 CASPubMedWeb of Science®Google Scholar Gehlert D. R., Schmidt C. J., Wu L., and Lovenberg W. (1985) Evidence for specific methylenedioxymethamphetamine (ecstasy) binding sites in the rat brain. Eur. J. Pharmacol. 119, 135–136. 10.1016/0014-2999(85)90334-6 PubMedWeb of Science®Google Scholar Gibb J. W., Stone D. M., Johnson M., and Hanson J. R. (1989) Neurochemical effects of MDMA, in MDMA: "Ecstasy" and/or Human Neurotoxin ( S. J. Peroutka, ed), pp. 133–150. Kluwer Academic Publishers, Norwell , Massachusetts . Google Scholar Greer G. and Tolbert R. (1986) Subjective reports of the effects of MDMA in a clinical setting. J. Psychoactive Drugs 18, 319–328. 10.1080/02791072.1986.10472364 CASPubMedWeb of Science®Google Scholar Hekmatpanah C. R., McKenna D. J., and Peroutka S. J. (1989) Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity. Neurosci. Lett, (in press). 10.1016/0304-3940(89)90351-0 PubMedWeb of Science®Google Scholar Hillarp N.-A., Fuxe K., and Dahlstrom A. B. (1966) Demonstration and mapping of central neurons containing dopamine, noradrenaline, and 5-hydroxytryptamine and their reactions to psychopharmaca. Pharmacol. Rev. 18, 727–741. CASPubMedWeb of Science®Google Scholar Hotchkiss A. and Gibb J. W. (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214, 257–262. CASPubMedWeb of Science®Google Scholar Johnson M. P., Hoffman A. J., and Nichols D. E. (1986) Effects of the enantiomers of MDA, MDMA, and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices. Eur. J. Pharmacol. 132, 269–276. 10.1016/0014-2999(86)90615-1 CASPubMedWeb of Science®Google Scholar Johnson M., Hanson G. R., and Gibb J. W. (1987) Effects of JV-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat. Biochem. Pharmacol. 36, 4085–4093. 10.1016/0006-2952(87)90565-X CASPubMedWeb of Science®Google Scholar Johnson M., Hanson G. R., and Gibb J. W. (1988a) Effects of dopaminergic and serotonergic receptor blockade on neurochemical changes induced by acute administration of methamphetamine and 3,4-methylenedioxymethamphetamine. Neuropharmacology 27, 1089–1096. 10.1016/0028-3908(88)90002-0 PubMedWeb of Science®Google Scholar Johnson M., Letter A. A., Merchant K., Hanson G. R., and Gibb J. W. (1988b) Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat. J. Pharmacol. Exp. Ther. 244, 977–982. CASPubMedWeb of Science®Google Scholar Kleven M. S., Schuster C. R., and Seiden L. S. (1988) Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine. J. Pharmacol. Exp. Ther. 246, 822–828. CASPubMedWeb of Science®Google Scholar Lyon R. A., Glennon R. A., and Titeler M. (1986) 3,4-Methylenedi-oxymethamphetamine (MDMA): stereoselective interactions at brain 5HT1, and 5HT2 receptors. Psychopharmacology 88, 525–526. 10.1007/BF00178519 CASPubMedWeb of Science®Google Scholar Merchant K. M., Letter A. A., Johnson M., Stone D. M., Gibb J. W., and Hanson G. R. (1987) Effects of amphetamine analogues on neurotensin concentrations in rat brain. Eur. J. Pharmacol. 138, 151–154. 10.1016/0014-2999(87)90353-0 CASPubMedWeb of Science®Google Scholar Mokler D. J., Robinson S. E., and Rosecrans J. A. (1987) (±)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats. Eur. J. Pharmacol. 138, 265–268. 10.1016/0014-2999(87)90441-9 CASPubMedWeb of Science®Google Scholar Molliver M. E. (1987) Serotonergic neuronal systems: what their anatomic organization tells us about function. J. Clin. Psycho-pharmacol. 7, 3S–23S. 10.1097/00004714-198712001-00002 CASPubMedWeb of Science®Google Scholar Molliver M. E., O'Hearn E., Battaglia G., and De Souza E. B. (1986) Direct intracerebral administration of MDA and MDMA does not produce serotonin neurotoxicity. Soc. Neurosci. Abst. 12, 1234. Google Scholar Nash J. F., Meltzer H. Y., and Gudelsky G. A. (1988) Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphet-amine. J Pharmacol Exp Ther. 245, 873–879. CASPubMedWeb of Science®Google Scholar Nichols D. E. (1986) Differences between the mechanism of action of MDMA, MBDB. and the classic hallucinogens. Identification of a new therapeutic class: entactogens. J. Psychoactive Drugs 18, 305–313. 10.1080/02791072.1986.10472362 CASPubMedWeb of Science®Google Scholar Nichols D. E., Lloyd D. H., Hoffman A. J., Nichols M. B., and Yim G. K. (1982) Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes. J. Med. Chem. 25, 530–535. 10.1021/jm00347a010 CASPubMedWeb of Science®Google Scholar O'Hearn E., Battaglia G., De Souza E. B., Kuhar M. J., and Molliver M. E. (1988) Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetarnine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J. Neurosci. 8, 2788–2803. CASPubMedWeb of Science®Google Scholar Peat M. A., Warren P. F., Bakhit C., and Gibb J. W. (1985) The acute effects of methamphetamine, amphetamine and p-chloro-amphetamine on the cortical serotonergic system of the rat brain: evidence for differences in the effects of methamphetamine and amphetamine. Eur. J. Pharmacol. 116, 11–16. 10.1016/0014-2999(85)90179-7 CASPubMedWeb of Science®Google Scholar Peroutka S. J. (1987) Incidence of recreational use of 3,4-methylene-dioxymethamphetamine (MDMA, "Ecstasy") on an undergraduate campus. N. Eng J. Med. 317, 1542–1543. 10.1056/NEJM198712103172419 CASPubMedWeb of Science®Google Scholar Peroutka S. J. (1988) Relative insensitivity of mice to 3,4-methylene-dioxymethamphetamine neurotoxicity. Res Commun. Subs. Abuse 9, 193–206. CASWeb of Science®Google Scholar Pierce P. A. and Peroutka S. J. (1988) Ring-substituted amphetamine interactions with neurotransmitter receptor binding sites in human cortex. Neurosci. Lett. 95, 208–212. 10.1016/0304-3940(88)90658-1 CASPubMedWeb of Science®Google Scholar Pierce P. A. and Peroutka S. J. (1989) Evidence for distinct 5-hydroxytryptamine2 binding site subtypes in cortical membrane preparations. J. Neurochem. 52, 656–658. 10.1111/j.1471-4159.1989.tb09171.x CASPubMedWeb of Science®Google Scholar Ricaurte G., Bryan G., Strauss L., Seiden L., and Schuster C. (1985) Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science 229, 986–988. 10.1126/science.4023719 CASPubMedWeb of Science®Google Scholar Ricaurte G. A., Finnigan K. F., Nichols D. E., DeLanney L. E., Irwin I., and Langston J. W. (1987) 3,4-Methylenedioxyethylamphet-amine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain. Eur. J. Pharmacol. 137, 265–268. 10.1016/0014-2999(87)90233-0 CASPubMedWeb of Science®Google Scholar Ricaurte G. A., DeLanney L. E., Irwin I., and Langston J. W. (1988a) Toxic effect of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Res. 446, 165–168. 10.1016/0006-8993(88)91309-1 CASPubMedWeb of Science®Google Scholar Ricaurte G. A., DeLanney L. E., Weiner S. G., Irwin I., and Langston J. W. (1988b) 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxy-methamphetamine in CNS of non-human primates. Brain Res. 474, 359–363. 10.1016/0006-8993(88)90451-9 CASPubMedWeb of Science®Google Scholar Sanders-Bush E. and Sterenka L. R. (1978) Immediate and long-term effects of p-chloroamphetamine on brain amines. Ann. NY Acad. Sci. 305, 208–221. 10.1111/j.1749-6632.1978.tb31525.x CASPubMedGoogle Scholar Sanders-Bush E., Bushing J. A., and Sulser F. (1975) Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanism. J. Pharmacol. Exp. Ther. 192, 33–41. CASPubMedWeb of Science®Google Scholar Schmidt C. J. (1987a) Acute administration of methylenedioxyamphetamine: comparison with the neurochemical effects of its N - desmethyl and N-ethyl analogues. Eur. J. Pharmacol. 136, 81–88. 10.1016/0014-2999(87)90782-5 CASPubMedWeb of Science®Google Scholar Schmidt C. J. (1987b) Neurotoxicity of the psychedelic amphetamine, mefhylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 240, 1–7. CASPubMedWeb of Science®Google Scholar Schmidt C. J. and Gibb J. W. (1985) Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid. Eur. J. Pharmacol. 109, 73–80. 10.1016/0014-2999(85)90541-2 CASPubMedWeb of Science®Google Scholar Schmidt C. J. and Taylor V. L. (1987) Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetarnine. Biochem. Pharmacol. 36, 4095–4102. 10.1016/0006-2952(87)90566-1 CASPubMedWeb of Science®Google Scholar Schmidt C. J. and Taylor V. L. (1989) Neurochemical effects of methylenedioxymethamphetarnine in the rat: acute versus long-term changes, in MDMA: Ecstasy and/or Human Neurotoxin ( S. J. Peroutka, ed), pp. 151–169. Kluwer Academic Publishers, Norwell , Massachusetts . Google Scholar Schmidt C. J., Ritter J. K., Sonsalla P. K., Hanson G. R., and Gibb J. W. (1985) Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp Ther. 233, 539–544. CASPubMedWeb of Science®Google Scholar Schmidt C. J., Wu L., and Lovenberg W. (1986) Methylenedioxymethamphetarnine: a potentially neurotoxic amphetamine analogue. Eur. J. Pharmacol. 124, 175–178. 10.1016/0014-2999(86)90140-8 CASPubMedWeb of Science®Google Scholar Schmidt C. J., Levin J. A., and Lovenberg W. (1987) In vitro and in vivo neurochemical effects of methylenedioxymethamphetarnine on striatal monoaminergic systems in the rat brain. Biochem. Pharmacol. 36, 747–755. 10.1016/0006-2952(87)90729-5 CASPubMedWeb of Science®Google Scholar Schuster C. R., Lewis M., and Seiden L. S. (1986) Fenfluramine neurotoxicity. Psychopharmacol. Bull. 22, 148–151. PubMedWeb of Science®Google Scholar Slikker W., Ali S. F., Scallet A.C., Frith C. H., Newport G. D., and Bailey J. R. (1988) Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetarnine (MDMA). Toxicol. Appl. Pharmacol. 94, 448–457. 10.1016/0041-008X(88)90285-2 CASPubMedWeb of Science®Google Scholar Steele T. D., Nichols D. E., and Yim G. K. W. (1987) Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]-monoamines into synaptosomes from different regions of rat brain. Biochem. Pharmacol. 36, 2297–2303. 10.1016/0006-2952(87)90594-6 CASPubMedWeb of Science®Google Scholar Stone D. M., Stahl D.C., Hanson G. R., and Gibb J. W. (1986) The effects of 3,4-methylenedioxymefhamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur. J. Pharmacol. 128, 41–48. 10.1016/0014-2999(86)90555-8 CASPubMedWeb of Science®Google Scholar Stone D. M., Johnson M., Hanson G. R., and Gibb J. W. (1987a) A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its Af-methylated and N-ethylated derivatives. Eur. J. Pharmacol. 134, 245–248. 10.1016/0014-2999(87)90173-7 CASPubMedWeb of Science®Google Scholar Stone D. M., Merchant K. M., Hanson G. R., and Gibb J. W. (1987b) Immediate and long-term effects of 3,4-methylenedioxymeth-amphetamine on serotonin pathways in brain of rat. Neuropharmacology 26, 1677–1683. 10.1016/0028-3908(87)90117-1 CASPubMedWeb of Science®Google Scholar Stone D. M., Hanson G. R., and Gibb J. W. (1987c) Differences in the central serotonergic effects of methylenedioxymethamphetarnine (MDMA) in mice and rats. Neuropharmacology 26, 1657–1661. 10.1016/0028-3908(87)90017-7 CASPubMedWeb of Science®Google Scholar Stone D. M., Johnson M., Hanson G. R., and Gibb J. W. (1988) Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 247, 79–87. CASPubMedWeb of Science®Google Scholar Wagner J. A. and Peroutka S. J. (1988) Comparative neurotoxicity of fenfluramine and 3,4-mefhylenedioxymethamphetamine (MDMA). Soc. Neurosci. Abst. 14, 327. Google Scholar Wang S. S., Ricaurte G. A., and Peroutka S. J. (1987) [3H]-3,4-Meth-ylenedioxymethamphetamine (MDMA) interactions with brain membranes and glass fiber filter paper. Eur. J. Pharmacol. 138, 439–443. 10.1016/0014-2999(87)90485-7 CASPubMedWeb of Science®Google Scholar Wilson M. A., Ricaurte G. A., and Molliver M. E. (1989) Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methyl-enedioxymethamphetamine. Neuroscience 28, 121–137. 10.1016/0306-4522(89)90237-6 CASPubMedWeb of Science®Google Scholar Yamamoto B. K. and Spanos L. J. (1988) The acute effects of methylenedioxymethamphetarnine on dopamine release in the awake-behaving rat. Eur. J. Pharmacol. 148, 195–203. 10.1016/0014-2999(88)90564-X CASPubMedWeb of Science®Google Scholar Yeh S. Y. and Hsu F.-L. (1987) Neurotoxicity of the metabolites of MDA and MDMA (Ecstasy) in the rat. Soc. Neurosci. Abst. 13, 906. Google Scholar Citing Literature Volume54, Issue1January 1990Pages 14-22 ReferencesRelatedInformation